Clone MY31 SK1 TB28-2 11F2 L17F12 SK7 (also known as Leu-4) SK3 (also known as Leu3a) L27 HB7 2D1 1-155-2 SJ25C1 (also known as SJ25-C1) (CE/IVD)
- Brand BD OneFlow™
- Reactivity Human (QC Testing)
Flow cytometry (Routinely Tested)
- Regulatory Status CE/IVD
Regulatory Status Legend
The BD OneFlow™ LST (Lymphoid Screening Tube) is intended for flow-cytometric immunophenotyping of normal and aberrant mature lymphocyte populations of B, T, and NK lineages in peripheral blood, bone marrow, and lymph nodes, as an aid in the diagnosis of hematological disorders. The BD OneFlow LST is designed for use with a suitably equipped BD flow cytometer and software designated for in vitro diagnostic use.
|Specificity||Clone||Format||Isotype||Entrez Gene ID|
|CD56 (NCAM-1)||MY31||PE||IgG1, κ|
|Ig, κ light chain||TB28-2||PE||IgG1, κ|
|gamma delta TCR||11F2||PE-Cy™7||IgG1|
|CD3||SK7 (also known as Leu-4)||APC||IgG1, κ||916|
|CD4||SK3 (also known as Leu3a)||V450||IgG1, κ||920|
|Ig,κ light chain||1-155-2||FITC||IgG1, κ|
|CD19||SJ25C1 (also known as SJ25-C1)||PE-Cy™7||IgG1, κ||930|
Preparation and Storage
Store tubes at 2°C–27°C in the foil pouch. Do not freeze the reagent or expose it to direct light at any time during storage or incubation with cells. The dried fluorochrome-conjugated antibodies are stable until the expiration date shown on the pouch and tube labels when stored as directed. Do not use after the expiration date. Once the pouch is opened, the dried fluorochrome-conjugated antibodies are stable for one month when stored as directed.
CAUTION Ensure the pouch is completely resealed after removing a tube. The reagent is very sensitive to moisture. Do not remove the desiccant from the reagent pouch.
Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline—Third Edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2005. CLSI document M29-A3.
Appendix C. Summary of antibody names, code numbers, and donor laboratories. In: McMichael AJ, Beverley PC, Cobbold S, et al, eds. Leucocyte Typing III: White Cell Differentiation Antigens. New York, NY: Oxford University Press; 1987:988-993.
Bernard A, Boumsell L, Hill C. Joint report of the first international workshop on human leucocyte differentiation antigens by the investigators of the participating laboratories. In: Bernard A, Boumsell L, Dausset J, Milstein C, Schlossman SF, eds. Leucocyte Typing. New York, NY: Springer-Verlag; 1984:9-108.
Borst J, van Dongen J, Bolhuis R, et al. Distinct molecular forms of human T cell receptor γ/δ detected on viable T cells by a monoclonal antibody. J Exp Med. 1988;167:1625-1644.
Centers for Disease Control. Perspectives in disease prevention and health promotion update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR. 1988;37:377-388.
Cobbold SP, Hale G, Waldmann H. Non-lineage, LFA-1 family, and leucocyte common antigens: new and previously defined clusters. In: McMichael AJ, Beverley PC, Cobbold S, et al, eds. Leucocyte Typing III: White Cell Differentiation Antigens. New York, NY: Oxford University Press; 1987:788-803.
Engleman EG, Warnke R, Fox RI, Dilley J, Benike CJ, Levy R. Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. Proc Natl Acad Sci USA. 1981;78:1791-1795.
Ichinohasama R, Miura I, Takahashi T, et al. Peripheral CD4+ CD8– γδ T cell lymphoma: a case report with multiparameter analyses. Hum Pathol. 1996;27:1370-1377.
Kalina T, Flores-Montero J, van der Velden VH, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012;26:1986-2010.
Knowles RW. Immunochemical analysis of the T-cell–specific antigens. In: Reinherz EL, Haynes BF, Nadler LM, Bernstein ID, eds. Leukocyte Typing II: Human T Lymphocytes. Vol 1. New York, NY: Springer-Verlag; 1986:259-288.
Kubagawa H, Gathings WE, Levitt D, Kearney JF, Cooper MD. Immunoglobulin isotype expression of normal pre-B cells as determined by immunofluorescence. J Clin Immunol. 1982;2:264-269.
Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986;136:4480-4486.
Ling NR, Maclennan ICM, Mason DY. B-cell and plasma cell antigens: new and previously defined clusters. In: McMichael AJ, Beverley PC, Cobbold S, et al, eds. Leucocyte Typing III: White Cell Differentiation Antigens. New York, NY: Oxford University Press; 1987:302-335.
Nadler LM. B Cell/Leukemia Panel Workshop: Summary and Comments. In: Reinherz EL, Haynes BF, Nadler LM, Bernstein ID, eds. Leukocyte Typing II: Human B Lymphocytes. Vol 2. New York, NY: Springer-Verlag; 1986:3-43.
Ritz J, Trinchieri G, Lanier LL. NK-cell antigens: section report. In: Schlossman SF, Boumsell L, Gilks W, et al, eds. Leucocyte Typing V: White Cell Differentiation Antigens. Vol 2. New York, NY: Oxford University Press; 1995:1367-1372.
Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Leukemia. 1996;10:877-895.
Stelzer GT, Marti G, Hurley A, McCoy PJ, Lovett EJ, Schwartz A. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry. 1997;30:214-230.